Ctip1/BCL-11A Antibody (Mouse mAb) [A3G8]

Catalog No.: F7747

    Application: Reactivity:

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    使用情報

    Dilution
    1:1000
    1:2000
    Application
    WB, FCM
    Source
    Mouse Monoclonal Antibody
    Reactivity
    Mouse, Human
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW Observed MW
    91 kDa 120 kDa, 42 kDa,62 kDa
    *なぜ予測分子量と実際の分子量が異なるのか?
    下記の原因により、実際の分子量が予測と異なる:タンパク質の翻訳後修飾(リン酸化/糖鎖付加),スプライシングバリアント,イソフォーム,相対的な電荷,ポリマー。

    Datasheet & SDS

    生物学的記述

    Specificity
    Ctip1/BCL-11A Antibody (Mouse mAb) [A3G8] detects endogenous levels of total Ctip1/BCL-11A protein.
    Clone
    A3G8
    Synonym(s)
    CTIP1, EVI9, KIAA1809, ZNF856, BCL11A, BCL11 transcription factor A, B-cell CLL/lymphoma 11A, Zinc finger protein 856, BCL-11A, EVI-9
    Background
    CTIP1/BCL11A is a multi‑zinc‑finger transcription factor that occupies defined regulatory elements in both the β‑globin locus and the developing neocortex, where it organizes long‑range chromatin interactions and directs lineage‑specific transcriptional programs. At the human β‑globin cluster, BCL11A binds the locus control region, the ε‑globin promoter, and intergenic regions between the γ‑ and δ‑globin genes, forming a binding pattern that coincides with the fetal‑to‑adult hemoglobin switch and with a chromatin architecture in which the LCR contacts the adult β‑globin gene while interactions with γ‑globin promoters are reduced. Chromosome conformation capture and ChIP–chip data show that BCL11A participates in reconfiguring these loops and co‑occupies key sites with SOX6 and GATA1, and functional assays in adult human erythroid progenitors demonstrate that BCL11A and SOX6 cooperate to silence γ‑globin transcription, establishing BCL11A as a central component of the HbF repression complex. Genome‑wide analyses and genetic studies link erythroid BCL11A expression with HbF levels, and modulation of its dosage alters γ‑globin output in proportion to its occupancy at these regulatory elements, so BCL11A is now positioned as a primary target for HbF reactivation strategies in β‑hemoglobinopathies. In the cerebral cortex, Ctip1 is expressed by postmitotic deep‑layer projection neurons, including corticothalamic and callosal neurons, and is excluded from corticospinal motor neurons that express the related factor Ctip2, producing complementary expression domains across layer 5 and 6. Loss‑of‑function experiments show that Ctip1 is required to maintain the correct balance of deep‑layer projection neuron subtypes: deletion of Ctip1 in sensory cortex produces an excess of subcerebral projection neurons at the expense of corticothalamic and deep‑layer callosal neurons, whereas misexpression of Ctip1 represses subcerebral gene expression and their descending projections, demonstrating subtype‑specific control at the transcriptional level. Direct transcriptional targets include the cortical fate determinant Tbr1, whose repression by CTIP1 in layer 5 is necessary for acquisition of subcerebral identity, and guidance and connectivity genes such as Sema3c, which mediate neuronal polarization and radial migration of later‑born upper‑layer neurons via a defined Ctip1/Sema3c pathway. Across these systems, CTIP1/BCL11A acts through its clustered zinc fingers and corepressor‑interacting domains to bind specific promoter and enhancer sequences, assemble repressive or modulatory complexes, remodel chromatin topology, and thereby couple local transcriptional decisions to large‑scale changes in locus conformation and projection neuron wiring, linking erythroid hemoglobin switching and cortical output specification through a common transcriptional logic.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください